Abstract
Rhinocerebral mucormycosis is extremely difficult to treat. Approximately 70% of patients are poorly controlled diabetics, and many of the remainder are immunocompromised as a consequence of cytotoxic drugs, burn injuries, or end-stage renal disease. Despite standard treatment consisting of surgical debridement and the intravenous administration of amphotericin B, rhinocerebral mucormycosis is usually a fatal disease. We describe the case of a 16-year-old male patient with juvenile onset diabetes mellitus who presented with fever, right-sided hemiparesis, and dysarthria. Axial view computed tomography revealed abscess formation in the left basal ganglia and frontal lobe, which was proven by stereotactic biopsy to contain Rhizopus oryzae. Intravenous administration of amphotericin B (30-280 mg/dose) was begun on the day of admission. On hospital Day 20, after the occurrence of frank abscess formation, the lesion was aggressively debrided. Despite these therapies, there was neurological deterioration characterized by the development of hemiplegia and aphasia. Sequential computed tomographic scans enhanced with contrast medium demonstrated progressively enlarging lesions. Ommaya reservoirs were placed into the abscess cavity and t...Continue Reading
References
Jan 1, 1978·Journal of Clinical Microbiology·K W Jones, L Kaufman
Feb 1, 1978·Antimicrobial Agents and Chemotherapy·A J Atkinson, J E Bennett
Oct 1, 1977·Archives of Otolaryngology·H C Pillsbury, N D Fischer
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A M Sugar
Mar 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R D Meyer
Jun 11, 1992·The Laryngoscope·V K AnandJ A Griswold
Jul 1, 1991·The Journal of Laryngology and Otology·E W FisherA D Cheesman
Jan 1, 1989·The American Journal of Medicine·G M StaveT M Kerkering
Jan 1, 1988·Archives of Neurology·L M CuadradoD Garcia Urra
Mar 1, 1986·Medicine·N A Parfrey
Jun 1, 1985·Archives of Neurology·R Rangel-GuerraC Sáenz
Sep 1, 1985·Journal of Neurosurgery·R F YoungV Grinnell
Nov 18, 1971·The New England Journal of Medicine·R SandlerW R Irving
Oct 30, 1970·Annals of the New York Academy of Sciences·R D Baker
Jul 1, 1980·Annals of Internal Medicine
May 1, 1981·Annals of Neurology·W E Bell
May 1, 1982·Archives of Neurology·E F MasucciJ F Kurtzke
Apr 1, 1980·The Laryngoscope·A BlitzerH F Biller
Jul 10, 1993·Lancet·J J LangmayrK Twerdy
Feb 1, 1994·Surgical Neurology·E S Nussbaum, W A Hall
Jan 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D Armstrong
Mar 9, 1957·Journal of the American Medical Association·R D BAKER
Dec 1, 1958·A.M.A. Archives of Otolaryngology·H W SMITH, J A KIRCHNER
Apr 1, 1959·The American Journal of Medicine·E L LONG, D L WEISS
Citations
Apr 10, 2002·Pharmacotherapy·Kristin E MondyLinda M Mundy
Jun 28, 2018·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·Casey VaughanSamuel C Leong
Jul 31, 2019·Clinical Case Reports·Bruno GallettiFrancesco Galletti
May 1, 2020·Clinical Microbiology Reviews·Roland NauHelmut Eiffert
Jun 30, 2009·Pharmacotherapy·Aaron M CookJimmi Hatton
Sep 11, 2003·Medical Mycology·W BuzinaH Stammberger
Dec 12, 2013·Italian Journal of Pediatrics·Annalisa di CosteMarzia Duse
Aug 1, 2006·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Koen De DeckerPhilippe G Jorens
Feb 23, 2020·Critical Care Nursing Quarterly·Michael J ErdmanClay E Small
Nov 15, 2007·Antimicrobial Agents and Chemotherapy·Yoshifumi ImamuraMahmoud A Ghannoum
Oct 15, 2003·Clinical Microbiology Reviews·Philip A Thomas
Nov 23, 2006·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Petr SchützLarry L Cunningham